ProPharma Sets New Standards in Sustainability
As a leader in life sciences consulting, ProPharma has taken a substantial step forward by achieving validation for its greenhouse gas (GHG) reduction targets from the Science Based Targets initiative (SBTi). This endorsement confirms that ProPharma's climate commitment aligns with the SBTi Net-Zero Standard, recognized as the planet’s first science-based framework designed to ensure corporate transparency and accountability regarding net-zero objectives.
Commitment to Net-Zero Emissions
ProPharma has pledged to achieve net-zero emissions by 2050 and maintain zero absolute emissions for both Scope 1 and Scope 2. This commitment demonstrates the company's alignment with the Paris Agreement's 1.5°C pathway, highlighting its proactive approach to combating climate change.
A Leaders Voice on Climate Impact
Chief Executive Officer Dawn Sherman stated, "This milestone reflects our commitment to taking credible, science-based action on climate. We, as a global partner to the life sciences industry, recognize our responsibility to align our operations with climate science while supporting innovation that improves patient health worldwide.”
Ambitious Emission Reduction Targets
ProPharma's sustainability initiative includes a goal to achieve a 90% absolute reduction in Scope 3 emissions by 2050. Such a significant reduction sets a new benchmark for sustainability among consulting firms globally. Furthermore, by 2035, ProPharma aims to lower emissions from purchased goods and services by 37.5%. This substantial reduction is expected to assist pharmaceutical partners in decreasing their carbon footprints, thus fostering a collaborative endeavor towards sustainability.
Measurable Results for Our Planet
By committing to these targets, ProPharma anticipates a tangible decrease in metric tons of CO2 equivalent across its global operations. This alignment with science-based frameworks enables not only tracking progress but also ensures accountability at every stage of its environmental initiatives.
Strategic Approaches for Sustainable Growth
ProPharma's validated science-based targets lay out a comprehensive roadmap for significantly reducing emissions through enhanced operational efficiency. The company's initiatives include sustainable resource management, employee training, and an annual review of energy consumption and carbon reporting. By promoting remote work and establishing Green Team programs, ProPharma is setting an example for environmental stewardship in the consulting sector.
Continuous Improvement in Sustainability
ProPharma's dedication to transparency, accountability, and continuous enhancement in environmental, social, and governance (ESG) practices reflects its commitment to advancing sustainability while driving healthcare innovations. This ongoing endeavor supports both environmental objectives and the overarching mission to deliver breakthroughs in healthcare.
About ProPharma
ProPharma has dedicated over 25 years to enhancing patient health and wellness by delivering expert consulting services to biotech, medical device, and pharmaceutical companies. Its deep expertise spans regulatory sciences, clinical research solutions, quality assurance and compliance, pharmacovigilance, medical information, and digital transformation. ProPharma provides a customizable range of consulting solutions that help mitigate risks and accelerate the advancement of groundbreaking drugs and therapies.
About Odyssey Investment Partners
With a history of more than 25 years, Odyssey Investment Partners excels at partnering with experienced managers to transform middle-market companies into nimble and diversified businesses. Their strategic investments target sectors anticipated to experience long-term growth, ensuring a positive economic outlook.
Frequently Asked Questions
What are ProPharma's net-zero targets?
ProPharma aims to achieve net-zero emissions by 2050, while also committing to zero Scope 1 and 2 emissions.
How will ProPharma reduce its Scope 3 emissions?
The company targets a 90% absolute reduction in Scope 3 emissions by 2050, focusing on emissions from purchased goods and services.
What initiatives support ProPharma's sustainability goals?
ProPharma's initiatives include remote work, employee education, annual EcoVadis assessments, and energy reporting to ensure sustainability.
Why is the SBTi validation significant?
The SBTi validation confirms that ProPharma's emissions reduction targets meet stringent science-based criteria for corporate responsibility.
How long has ProPharma been improving patient health?
ProPharma has been in the industry for over 25 years, helping advance scientific breakthroughs and improve health outcomes.
